These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8343984)

  • 1. Sheep brain pseudocholinesterase: inhibition kinetics of the partially purified enzyme by some substrate analogues.
    Cokuğraş AN; Tezcan EF
    Chem Biol Interact; 1993 Jun; 87(1-3):259-64. PubMed ID: 8343984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition by D-tubocurarine of horse serum cholinesterase-catalyzed hydrolysis of butyrylcholine and benzoylcholine.
    Kamarić LM
    Biochem Pharmacol; 1975 Sep; 24(18):1663-4. PubMed ID: 1191325
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymorphism of pseudocholinesterase in Torpedo marmorata tissues: comparative study of the catalytic and molecular properties of this enzyme with acetylcholinesterase.
    Toutant JP; Massoulié J; Bon S
    J Neurochem; 1985 Feb; 44(2):580-92. PubMed ID: 2578181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition kinetics of human serum butyrylcholinesterase by Cd2+, Zn2+ and Al3+: comparison of the effects of metal ions on cholinesterases.
    Sarkarati B; Cokuğraş AN; Tezcan EF
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1999 Feb; 122(2):181-90. PubMed ID: 10190043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
    Yang HS; Goudsouzian N; Martyn JA
    Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a pseudocholinesterase purified from surgeonfish tissues confirms the atypical nature of this enzyme.
    Leibel WS
    J Exp Zool; 1988 Sep; 247(3):198-208. PubMed ID: 3183591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new perspective on thermal inactivation kinetics of human serum butyrylcholinesterase.
    Cengiz D; Cokuğraş AN; Tezcan EF
    J Protein Chem; 2002 Mar; 21(3):145-9. PubMed ID: 12018615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid.
    Jayanthi LD; Balasubramanian N; Balasubramanian AS
    Clin Chim Acta; 1992 Feb; 205(3):157-66. PubMed ID: 1349516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase.
    Boeck AT; Schopfer LM; Lockridge O
    Biochem Pharmacol; 2002 Jun; 63(12):2101-10. PubMed ID: 12110369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of an acetylcholinesterase from the infective juveniles of Heterorhabditis bacteriophora.
    Mohamed MA; Abdel-Gawad AS; Ghazy AE
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Sep; 146(3):314-24. PubMed ID: 17531543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrylcholinesterase: inhibition by arsenite, fluoride, and other ligands, cooperativity in binding.
    Page JD; Wilson IB; Silman I
    Mol Pharmacol; 1985 Apr; 27(4):437-43. PubMed ID: 3982389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptidase activity exhibited by human serum pseudocholinesterase.
    Boopathy R; Balasubramanian AS
    Eur J Biochem; 1987 Jan; 162(1):191-7. PubMed ID: 3545820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification and characterization of soluble isoform of butyrylcholinesterase from rat intestine.
    Yildiz O; Bodur E; Cokuğraş AN; Ozer N
    Protein J; 2004 Feb; 23(2):143-51. PubMed ID: 15106880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.
    Neville LF; Gnatt A; Padan R; Seidman S; Soreq H
    J Biol Chem; 1990 Dec; 265(34):20735-8. PubMed ID: 2249982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of eserine action on the hydrolysis of butyrylthiocholine by butyrylcholinesterase.
    Stojan J; Pavlic MR
    J Enzyme Inhib; 1997 Jan; 11(3):199-208. PubMed ID: 9204388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P hydrolysis by human serum cholinesterase.
    Lockridge O
    J Neurochem; 1982 Jul; 39(1):106-10. PubMed ID: 6177830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
    Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
    Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow microcalorimetric study of butyrylcholinesterase kinetics and inhibition.
    Debord J; Verneuil B; Bollinger JC; Merle L; Dantoine T
    Anal Biochem; 2006 Jul; 354(2):299-304. PubMed ID: 16725100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-productive binding of butyryl(thio)choline in the active site of vertebrate acetylcholinesterase.
    Stojan J
    Chem Biol Interact; 2010 Sep; 187(1-3):128-34. PubMed ID: 20452336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease.
    Schätz CR; Geula C; Mesulam M
    Neurosci Lett; 1990 Sep; 117(1-2):56-61. PubMed ID: 2290622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.